← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2018Last known activity
Oct 31, 2022
Timeline
2010s
- Sep 1, 2018
Versus Arthritis— Founded
Drugs by trial phase (17 distinct, 12 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- Antiphospholipid Syndrome
- Arthritis
- Arthritis, Rheumatoid
- Carpal Tunnel Syndrome
- Chronic Pain
- Granulomatosis with Polyangiitis
- Microscopic Polyangiitis
- Osteoarthritis
- Osteoarthritis, Knee
- Scleroderma, Diffuse
- Scleroderma, Systemic
- Sclerosis
- Syndrome
- Systemic Vasculitis
- Vasculitis
Recent trials (12)
- NCT05561010CollaboratorN/AOct 31, 2022
- NCT04927390CollaboratorPhase 2Nov 1, 2021
- NCT03684564CollaboratorPhase 2/Phase 3Jan 31, 2019
- NCT03514979CollaboratorPhase 2Jun 30, 2018
- NCT03708718CollaboratorPhase 2Dec 21, 2017
- NCT03146689CollaboratorN/AMay 1, 2017
- NCT02208778CollaboratorPhase 4Dec 1, 2014
- NCT02038452CollaboratorPhase 4Apr 1, 2014
- NCT02046668CollaboratorPhase 4Nov 1, 2013
- NCT01697267CollaboratorPhase 3Apr 1, 2013
- NCT01352858CollaboratorPhase 1Feb 1, 2012
- NCT01021735CollaboratorPhase 4Apr 1, 2010
Details
- Founded
- Chesterfield, GB Sep 1, 2018
- Last known activity
- Oct 31, 2022